May 14, 2010 — A new pooled analysis of randomized trials of tissue plasminogen activator (tPA) in the treatment of acute ischemic stroke, now expanded to include more recent trials, confirms the ...

FRESNO, Calif. (KFSN) -- Stroke is the third leading cause of death in the U.S. claiming the lives of more than 140,000 Americans each year. But many lives could be spared if treatment was given ...

A phase 2 study has suggested that the glycoprotein (gp) IIb/IIIa blocker eptifibatide can be safely combined with a reduced dose of tPA in the treatment of acute ischemic stroke, and there was a ...

Stroke victims treated with TPA were twice as likely to have a good outcome as those who were not. The Food and Drug Administration approved it for stroke the next year, and a move grew to treat ...

Biomed's NA-911 represents a breakthrough in stroke treatment, focusing on neurogenesis showing potential in the treatment of stroke and facilitating recovery. NA-911 marks a significant breakthrough ...

DEAR MAYO CLINIC: My neighbor had a stroke and received a "clot buster" medication. Then, I found out my uncle had a surgery after a stroke. Can you help me understand different kinds of stroke ...

Punjab Chief Minister Maryam Nawaz has ordered the establishment of a network of stroke centers across the province to ensure ...